Phase Space Research

Datadog

DDOG · Investment summary · as of 12 August 2026

Priced for an operating path the record does not support

Portfolio decision
No position
Price · 12 August 2026
$246.78
12-month target
$179.82 -27%
Expected return
-27.1%
Next decision point
Date not announced

Business type: Inflection · scaling but economically observable

The business does not meet the quality standard for its economic type.

Investment view

At $246.78, DDOG requires a 52% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at 32%.

The value rests on an exit multiple of 11.6x, a terminal operating margin of 30% and a 9.8% cost of capital. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.

The strongest argument against this view: Named cause: PERMANENT CONTRACTION OF THE AI-NATIVE CUSTOMER COHORT, of which Datadog's single largest customer is a member.

Underwriting bridge

QuestionEvidence-based conclusion
What drives the business?STATE C evidence, itemised: positive and stable gross margin (79.51% TTM, 78.6-80.4% across the last eight quarters); identifiable expense scaling (R&D, S&M and G&A all declining as a share of revenue); a formally guided operating model (FY2026 non-GAAP operating income $1.01-1.03bn on $4.45-4.47bn revenue, issued 6 August 2026); cohort data disclosed at low resolution (4,720 customers >= $100k ARR generating 91% of ARR; 33,400 total customers); and a reverse DCF that returns solutions across the entire admissible multiple range rather than 'no solution in range'.
What do we forecast?Revenue growth of 32% demonstrated; a terminal operating margin of 30%; an exit multiple of 11.6x.
What does Street forecast?Not determined — no consensus estimates are joined to this record
Where do we differ?On revenue growth, the difference between what the price requires and what the business has demonstrated is -20.1 percentage points.
What is it worth?Twelve-month target $179.82, -27% from the struck price. Scenario-weighted expected return net of costs -27.1%.
Why now?Date not announced — no dated event that would resolve the disagreement is on file

What must go right

  1. By Q3-2026, reported early November 2026Q3-2026 reported revenue at or above $1,135m (the low end of the company's own guide)Where it stands: quarterly revenue
  2. By any 10-Q from Q3-2026Dollar-based net retention rate disclosed at or above 120% (i.e. the band moves down out of 'low-120%'s')Where it stands: trailing-12-month dollar-based net retention
  3. By Q3-2026 and Q4-2026 10-QsRPO sequential growth vs revenue sequential growth stays clear of the 0 thresholdWhere it stands: RPO sequential growth vs revenue sequential growth

Catalysts and falsifiers

Date or windowEventThesis confirmed ifThesis weakened or refuted if
Q3-2026, reported early November 2026Quarterly revenueQ3-2026 reported revenue at or above $1,135m (the low end of the company's own guide)Q3-2026 reported revenue below $1,135m (the low end of the company's own guide)
any 10-Q from Q3-2026Trailing-12-month dollar-based net retentionDollar-based net retention rate disclosed at or above 120% (i.e. the band moves down out of 'low-120%'s')Dollar-based net retention rate disclosed below 120% (i.e. the band moves down out of 'low-120%'s')
Q3-2026 and Q4-2026 10-QsRPO sequential growth vs revenue sequential growthNeither leg of the condition opposite is met at this dateRemaining performance obligations grow slower than revenue for two further consecutive quarters (a fourth and fifth…
measured at each 10-Q from Q3-2026TTM GAAP operating marginNeither leg of the condition opposite is met at this dateTTM GAAP operating margin returns below zero

Risk and sell discipline

Impairment case

Named cause: PERMANENT CONTRACTION OF THE AI-NATIVE CUSTOMER COHORT, of which Datadog's single largest customer is a member. This is an impairment case, not a valuation bear case — it removes revenue at a named counterparty through a named mechanism and does not return it, rather than running the same model at a lower multiple.

Estimated probability 30%, against the 24% level at which the position would be resized. It sits above that level, so this case could not be carried at full size.

Fundamental invalidation

Falsifiable and fundamental — not one of them is a price condition.

Price-based risk trigger

A daily close below $197.18 triggers an immediate review of the thesis and pauses additional buying. It is not an automatic sell unless a separate fundamental invalidation condition has been breached.

Upside sell discipline

On approach to the $179.82 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.

Investment criteria

CriteriaStatusInvestment meaning
QualityNot metIs the business worth owning under its declared economic type?
ValuationNot determinedIs the operating path required by today's price achievable? Not established on the evidence on file.
LiquidityMetCan the intended position be built and exited in the right vehicle?
DownsideMetNamed cause: PERMANENT CONTRACTION OF THE AI-NATIVE CUSTOMER COHORT, of which Datadog's single largest customer is a member.
MomentumNot determinedDoes price action support or complicate entry timing? Not established on the evidence on file.
CatalystNot determinedIs there a dated event that resolves the disagreement? Not established on the evidence on file.
ConsensusNot determinedIs the house-versus-Street disagreement identified and quantified? Not established on the evidence on file.

Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.

Bottom line

The gap between what today's price requires and what the business has demonstrated is -20.1 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is whether the operating path today's price requires is achievable; the evidence does not settle it. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $197.18, which forces an immediate review.